Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

246 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Relative effectiveness of the second booster COVID-19 vaccines against laboratory confirmed SARS-CoV-2 infection in healthcare workers: VEBIS HCW VE cohort study (1 October 2022-2 May 2023).
Savulescu C, Prats-Uribe A, Brolin K, Uusküla A, Bergin C, Fleming C, Zvirbulis V, Zavadska D, Szułdrzyński K, Gaio V, Popescu CP, Craiu M, Cisneros M, Latorre-Millán M, Lohur L, McGrath J, Ferguson L, Abolina I, Gravele D, Machado A, Florescu SA, Lazar M, Subirats P, Clusa Cuesta L, Sui J, Kenny C, Krievins D, Barzdina EA, Melo A, Kosa AG, Miron VD, Muñoz-Almagro C, Milagro AM, Bacci S, Kramarz P, Nardone A; VEBIS HCW Study Group. Savulescu C, et al. Among authors: munoz almagro c. Vaccine. 2024 Dec 25;45:126615. doi: 10.1016/j.vaccine.2024.126615. Online ahead of print. Vaccine. 2024. PMID: 39724693
The importance of microbiology reference laboratories and adequate funding for infectious disease surveillance.
Shaw D, Torreblanca RA, Amin-Chowdhury Z, Bautista A, Bennett D, Broughton K, Casanova C, Choi EH, Claus H, Corcoran M, Cottrell S, Cunney R, Cuypers L, Dalby T, Davies H, de Gouveia L, Deghmane AE, Desmet S, Domenech M, Drew R, Plessis MD, Duarte C, Fuursted K, Golden A, Almeida SCG, Henares D, Henriques-Normark B, Hilty M, Hoffmann S, Humphreys H, Jacobsson S, Johnson C, Jolley KA, Kawabata A, Kozakova J, Kristinsson KG, Krizova P, Kuch A, Ladhani S, Lâm TT, Ayala MEL, Lindholm L, Litt D, Maiden MCJ, Martin I, Martiny D, Mattheus W, McCarthy ND, Meehan M, Meiring S, Mölling P, Morfeldt E, Morgan J, Mulhall R, Muñoz-Almagro C, Murdoch D, Musilek M, Novakova L, Oftadeh S, Perez-Arguello A, Pérez-Vázquez MD, Perrin M, Prevost B, Roberts M, Rokney A, Ron M, Sanabria OM, Scott KJ, Sempere J, Siira L, de Lemos APS, Sintchenko V, Skoczyńska A, Slotved HC, Smith AJ, Taha MK, Toropainen M, Tzanakaki G, Vainio A, van der Linden MPG, van Sorge NM, Varon E, Moreno JV, Vohrnova S, von Gottberg A, Yuste J, Brueggemann AB. Shaw D, et al. Among authors: munoz almagro c. Lancet Digit Health. 2024 Dec 20:S2589-7500(24)00241-3. doi: 10.1016/S2589-7500(24)00241-3. Online ahead of print. Lancet Digit Health. 2024. PMID: 39709282 Free article. Review.
Serotype distribution of remaining invasive pneumococcal disease after extensive use of ten-valent and 13-valent pneumococcal conjugate vaccines (the PSERENADE project): a global surveillance analysis.
Garcia Quesada M, Peterson ME, Bennett JC, Hayford K, Zeger SL, Yang Y, Hetrich MK, Feikin DR, Cohen AL, von Gottberg A, van der Linden M, van Sorge NM, de Oliveira LH, de Miguel S, Yildirim I, Vestrheim DF, Verani JR, Varon E, Valentiner-Branth P, Tzanakaki G, Sinkovec Zorko N, Setchanova LP, Serhan F, Scott KJ, Scott JA, Savulescu C, Savrasova L, Reyburn R, Oishi K, Nuorti JP, Napoli D, Mwenda JM, Muñoz-Almagro C, Morfeldt E, McMahon K, McGeer A, Mad'arová L, Mackenzie GA, Eugenia León M, Ladhani SN, Kristinsson KG, Kozakova J, Kleynhans J, Klein NP, Kellner JD, Jayasinghe S, Ho PL, Hilty M, Harker-Jones MA, Hammitt LL, Grgic-Vitek M, Gilkison C, Gierke R, French N, Diawara I, Desmet S, De Wals P, Dalby T, Dagan R, Corcoran M, Colzani E, Chanto Chacón G, Castilla J, Camilli R, Ang M, Ampofo K, Almeida SCG, Alarcon P, O'Brien KL, Deloria Knoll M; PSERENADE Team. Garcia Quesada M, et al. Among authors: munoz almagro c. Lancet Infect Dis. 2024 Dec 17:S1473-3099(24)00588-7. doi: 10.1016/S1473-3099(24)00588-7. Online ahead of print. Lancet Infect Dis. 2024. PMID: 39706205 Free article.
Pneumococcal nasopharyngeal carriage in children and adults self-confined at home during a COVID-19 national lockdown.
Brotons P, Cisneros M, Pérez-Argüello A, Henares D, Lluansí A, Fernández de Sevilla M, Ciruela P, Blanco-Fuertes M, Launes C, Jordan I, Bassat Q, García-García JJ, Muñoz-Almagro C. Brotons P, et al. Among authors: munoz almagro c. PLoS One. 2024 Dec 5;19(12):e0315081. doi: 10.1371/journal.pone.0315081. eCollection 2024. PLoS One. 2024. PMID: 39636920 Free PMC article.
Incidence of SARS-CoV-2 Infection Among European Healthcare Workers and Effectiveness of the First Booster COVID-19 Vaccine, VEBIS HCW Observational Cohort Study, May 2021-May 2023.
Savulescu C, Prats-Uribe A, Brolin K, Lovrić Makarić Z, Uusküla A, Panagiotakopoulos G, Bergin C, Fleming C, Agodi A, Bonfanti P, Murri R, Zvirbulis V, Zavadska D, Szuldrzynski K, Machado A, Popescu CP, Craiu M, Cisneros M, Latorre-Millán M, Petrović G, Lohur L, Tryfinopoulou K, McGrath J, Ferguson L, Barchitta M, Spolti A, de Gaetano Donati K, Abolina I, Gravele D, Gaio V, Florescu SA, Lazar M, Subirats P, Clusa Cuesta L, Sarajlić G, Amerali M, Sui J, Kenny C, Rapisarda V, Rossi M, Lamonica S, Krievins D, Barzdina EA, Palmira Amaral A, Kosa AG, Miron VD, Muñoz-Almagro C, Milagro AM, Bacci S, Kramarz P, Nardone A, The Vebis Hcw Ve Study Group. Savulescu C, et al. Among authors: munoz almagro c. Vaccines (Basel). 2024 Nov 19;12(11):1295. doi: 10.3390/vaccines12111295. Vaccines (Basel). 2024. PMID: 39591197 Free PMC article.
World Pneumonia Day 2024: Fighting Pneumonia and Antimicrobial Resistance.
Cilloniz C, Dela Cruz CS, Dy-Agra G, Pagcatipunan RS Jr; Pneumo-Strategy Group. Cilloniz C, et al. Am J Respir Crit Care Med. 2024 Dec 1;210(11):1283-1285. doi: 10.1164/rccm.202408-1540ED. Am J Respir Crit Care Med. 2024. PMID: 39530671 Free PMC article. No abstract available.
Effectiveness of the autumn 2023 COVID-19 vaccine dose in hospital-based healthcare workers: results of the VEBIS healthcare worker vaccine effectiveness cohort study, seven European countries, season 2023/24.
Savulescu C, Prats-Uribe A, Brolin K, Uusküla A, Bergin C, Fleming C, Murri R, Zvirbulis V, Zavadska D, Gaio V, Popescu CP, Hrisca R, Cisneros M, Latorre-Millán M, Lohur L, McGrath J, Ferguson L, De Gaetano Donati K, Abolina I, Gravele D, Machado A, Florescu SA, Lazar M, Subirats P, Clusa Cuesta L, Sui J, Kenny C, Santangelo R, Krievins D, Barzdina EA, Valadas Henriques C, Kosa AG, Pohrib SM, Muñoz-Almagro C, Milagro A, Bacci S, Nardone A; VEBIS HCW VE study group; Collaborators in VEBIS HCW study group. Savulescu C, et al. Among authors: munoz almagro c. Euro Surveill. 2024 Oct;29(44):2400680. doi: 10.2807/1560-7917.ES.2024.29.44.2400680. Euro Surveill. 2024. PMID: 39484687 Free PMC article.
Enhanced echovirus 11 genomic surveillance in neonatal infections in Spain following a European alert reveals new recombinant forms linked to severe cases, 2019 to 2023.
Fernandez-Garcia MD, Garcia-Ibañez N, Camacho J, Gutierrez A, Sánchez García L, Calvo C, Moreno-Docón A, Menasalvas AI, Medina A, Perez-Ruiz M, Nieto Toboso MC, Muñoz-Almagro C, Launes C, Berengua C, Cabrerizo M; Spanish study group for Enterovirus and Parechovirus infections (PI22CIII-00035); Spanish study group for Enterovirus and Parechovirus infections. Fernandez-Garcia MD, et al. Among authors: munoz almagro c. Euro Surveill. 2024 Oct;29(44):2400221. doi: 10.2807/1560-7917.ES.2024.29.44.2400221. Euro Surveill. 2024. PMID: 39484685 Free PMC article.
Human gut microbiota composition associated with international travels.
Henares D, Monsalvez V, Brotons P, Machado ML, Capilla S, Gomila-Grange A, Bierge P, Cubero M, Q Pich O, Requena-Méndez A, Muñoz-Almagro C, Gasch O. Henares D, et al. Among authors: munoz almagro c. Travel Med Infect Dis. 2024 Sep-Oct;61:102747. doi: 10.1016/j.tmaid.2024.102747. Epub 2024 Jul 31. Travel Med Infect Dis. 2024. PMID: 39094984 Free article.
Impact of universal immunization program with monoclonal antibody nirsevimab on reducing the burden of serious bronchiolitis that need pediatric intensive care.
Alejandre C, Penela-Sánchez D, Alsina J, Agüera M, Soler A, Moussalam S, Muñoz-Almagro C, Brotons P, Cambra FJ, Forner OR, Balaguer M, Launes C, Jordan I. Alejandre C, et al. Among authors: munoz almagro c. Eur J Pediatr. 2024 Sep;183(9):3897-3904. doi: 10.1007/s00431-024-05634-z. Epub 2024 Jun 23. Eur J Pediatr. 2024. PMID: 38910199
246 results